Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer.
about
First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?Whether HER2-positive non-breast cancers are candidates for treatment with Ado-trastuzumab emtansine?Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: a Meta-analysis.Harnessing the fcμ receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia.Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells.Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine.Mechanisms of immune evasion in breast cancer.Metastatic and triple-negative breast cancer: challenges and treatment options
P2860
Q26746081-EE6D4DF8-EA78-443F-A4F8-CAE3D1773BD9Q28067696-AEB029D8-ADD0-411D-BD13-5F9140D45BAAQ33430735-62AD02E2-95B3-4872-8EF7-C2E923F5864BQ34718363-CAEF115E-256F-4B14-A48D-E1370B2ED2D1Q35933820-4046AB6C-213F-4DEC-92C4-52734ADC4F41Q38852051-F46019C2-A8B3-4990-8373-51508BEAE593Q46216419-32A79B0E-CBFB-45C4-BB23-DA0745F3F33CQ52714655-FA2290DB-93E6-4A3B-828D-EF2F59234CFAQ55347716-A8677C85-6214-4851-A9E6-C43116C02D89Q57105258-BF436D0B-F463-401F-8FB7-B7945A630B2E
P2860
Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Ado-trastuzumab emtansine (T-D ...... tive metastatic breast cancer.
@ast
Ado-trastuzumab emtansine (T-D ...... tive metastatic breast cancer.
@en
type
label
Ado-trastuzumab emtansine (T-D ...... tive metastatic breast cancer.
@ast
Ado-trastuzumab emtansine (T-D ...... tive metastatic breast cancer.
@en
prefLabel
Ado-trastuzumab emtansine (T-D ...... tive metastatic breast cancer.
@ast
Ado-trastuzumab emtansine (T-D ...... tive metastatic breast cancer.
@en
P2093
P2860
P356
P1476
Ado-trastuzumab emtansine (T-D ...... tive metastatic breast cancer.
@en
P2093
Bonnie L Boster
Chad M Barnett
Jessica M Baron
P2860
P304
P356
10.1177/1078155214527144
P577
2014-03-27T00:00:00Z